Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bocchino, D. Galati, M. De Martino, M. Napolitano, A. Trotta, A. Stanziola, A. Sanduzzi (Naples, Italy). Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications. Eur Respir J 2012; 40: Suppl. 56, 3151

Member's Comments

No comment yet.

Related content which might interest you: Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Analysis of CD4 lymphocyte profiles in sarcoidosis and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 105-107 Year: 2008 Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells Source: Annual Congress 2011 - T-cell subsets Year: 2011 Extensive alveoalar lymphocyte apoptosis in pulmonary sarcoidosis (PS) followed by clinical improvement. Two distinct apoptosis presentations? Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004 Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Alleviation of asthma in a murine model is associated with intrahepatic NKT and CD4 lymphocyte trapping: a potential role for the liver in the immune modulation of asthma Source: Annual Congress 2008 - Airway cell biology Year: 2008 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results) Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004 Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1171-1183 Year: 2016